204 related articles for article (PubMed ID: 32027482)
1. A Self-Assembled α-Synuclein Nanoscavenger for Parkinson's Disease.
Liu J; Liu C; Zhang J; Zhang Y; Liu K; Song JX; Sreenivasmurthy SG; Wang Z; Shi Y; Chu C; Zhang Y; Wu C; Deng X; Liu X; Song J; Zhuang R; Huang S; Zhang P; Li M; Wen L; Zhang YW; Liu G
ACS Nano; 2020 Feb; 14(2):1533-1549. PubMed ID: 32027482
[TBL] [Abstract][Full Text] [Related]
2. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.
Sharma N; Nehru B
Inflammopharmacology; 2018 Apr; 26(2):349-360. PubMed ID: 29027056
[TBL] [Abstract][Full Text] [Related]
3. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
[TBL] [Abstract][Full Text] [Related]
4. AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin's neuroprotection in a rotenone-induced mouse model of Parkinson's disease.
Parekh P; Sharma N; Sharma M; Gadepalli A; Sayyed AA; Chatterjee S; Kate A; Khairnar A
Metab Brain Dis; 2022 Dec; 37(8):2853-2870. PubMed ID: 36178640
[TBL] [Abstract][Full Text] [Related]
5. TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity.
Decressac M; Mattsson B; Weikop P; Lundblad M; Jakobsson J; Björklund A
Proc Natl Acad Sci U S A; 2013 May; 110(19):E1817-26. PubMed ID: 23610405
[TBL] [Abstract][Full Text] [Related]
6. A Curcumin Derivative Activates TFEB and Protects Against Parkinsonian Neurotoxicity
Wang Z; Yang C; Liu J; Chun-Kit Tong B; Zhu Z; Malampati S; Gopalkrishnashetty Sreenivasmurthy S; Cheung KH; Iyaswamy A; Su C; Lu J; Song J; Li M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098449
[No Abstract] [Full Text] [Related]
7. Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease.
Guo YL; Duan WJ; Lu DH; Ma XH; Li XX; Li Z; Bi W; Kurihara H; Liu HZ; Li YF; He RR
Acta Pharmacol Sin; 2021 Apr; 42(4):518-528. PubMed ID: 32724177
[TBL] [Abstract][Full Text] [Related]
8. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
Liu Z; Yu Y; Li X; Ross CA; Smith WW
Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
[TBL] [Abstract][Full Text] [Related]
9. Beta-asarone protects against MPTP-induced Parkinson's disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression.
Zhang QS; Wang ZH; Zhang JL; Duan YL; Li GF; Zheng DL
Biomed Pharmacother; 2016 Oct; 83():153-159. PubMed ID: 27470562
[TBL] [Abstract][Full Text] [Related]
10. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.
Teng Y; Zhao J; Ding L; Ding Y; Zhou P
Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic Oligomers and Fibrils Trapped in a Gel-like State of α-Synuclein Assemblies.
Kumar R; Das S; Mohite GM; Rout SK; Halder S; Jha NN; Ray S; Mehra S; Agarwal V; Maji SK
Angew Chem Int Ed Engl; 2018 May; 57(19):5262-5266. PubMed ID: 29524323
[TBL] [Abstract][Full Text] [Related]
12. Genetic and chemical activation of TFEB mediates clearance of aggregated α-synuclein.
Kilpatrick K; Zeng Y; Hancock T; Segatori L
PLoS One; 2015; 10(3):e0120819. PubMed ID: 25790376
[TBL] [Abstract][Full Text] [Related]
13. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
14. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
15. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
[TBL] [Abstract][Full Text] [Related]
16. Novel multifunctional dopamine D
Luo D; Sharma H; Yedlapudi D; Antonio T; Reith MEA; Dutta AK
Bioorg Med Chem; 2016 Nov; 24(21):5088-5102. PubMed ID: 27591013
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the anti-Parkinson's activity of sulphated polysaccharides from Chlamydomonas reinhardtii on the α-Synuclein mutants A30P, A53T, E46K, E57K and E35K.
Panigrahi GP; Rane AR; Vavilala SL; Choudhary S
J Biochem; 2019 Dec; 166(6):463-474. PubMed ID: 31385584
[TBL] [Abstract][Full Text] [Related]
18. In silico drug repositioning of FDA-approved drugs to predict new inhibitors for alpha-synuclein aggregation.
Jafaripour SS; Gharaghani S; Nazarshodeh E; Haider S; Saboury AA
Comput Biol Chem; 2020 Oct; 88():107308. PubMed ID: 32650066
[TBL] [Abstract][Full Text] [Related]
19. Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide.
Choi MG; Kim MJ; Kim DG; Yu R; Jang YN; Oh WJ
PLoS One; 2018; 13(4):e0195339. PubMed ID: 29608598
[TBL] [Abstract][Full Text] [Related]
20. The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.
Benskey MJ; Perez RG; Manfredsson FP
J Neurochem; 2016 May; 137(3):331-59. PubMed ID: 26852372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
